Vitazi.AI, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vitazi.AI, Inc. - overview
Established
2021
Location
Santa Fe, NM, US
Primary Industry
Healthcare Specialists
About
Based in New Mexico, US, and founded in 2021, Vitazi. AI, Inc. is a provider of a medical platform that enables customers to apply artificial intelligence analytics to their data sets to improve physician efficiency and diagnostic accuracy. In October 2021, Vitazi.
AI, Inc. raised venture funding from investor Tramway Venture Partners. As of April 2024, the company is led by CEO Jeremy Stueven. The company's flagship product, Vitazi-DR, is an AI system designed to streamline diabetic retinopathy screening.
Vitazi-DR analyzes for diabetic retinopathy (DR) and macular edema, debilitating conditions, and scans in under a minute. The company's platform assesses patients, meets quality standards, enhances reimbursement, and lessens the long-term cost of avoidable diseases like vision loss and blindness.
Current Investors
Vitazi.AI, Inc.
Primary Industry
Healthcare Specialists
Sub Industries
Healthcare, Healthcare IT, Optometrists & Opticians Products and Services, Medical Software
Website
www.vitazi.ai
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.